IMMUNE DISREGULATION IN MALARIA AND CONCOMMITANT MEASLES

疟疾和麻疹的免疫失调

基本信息

  • 批准号:
    2625778
  • 负责人:
  • 金额:
    $ 2.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-07-01 至 2001-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION Preliminary studies: Malarial parasite rates in villages were 57% in children and 41% in adults. A 30% increase in recorded cases was seen between 1995 and 1996. In May 1995 there was a measles outbreak with 29% mortality. Mortality was often associated with secondary bacterial infections, thus immunosuppression was suspected. Dr. Quakyi proposed that the TH1 responses elicited by malaria and the TH2 responses elicited by measles may result in anergy. Malarial AMA antibodies were similar by ELISA in both measles and non-measles groups, however, lower measles antibodies were observed for people with malaria parasitemia, than people who were parasite negative. These findings have an important public health indication for the endemic area Measles vaccinations will probably be less effective if given during the high parasitemia season, therefore, they should be given at the low malaria season. Children being vaccinated for measles at Yaounde hospital will be invited to return and have their blood drawn at regular intervals in order to determine the levels and duration of measles and malarial antibodies, the categorization of TH1/TH2 responses via cytokine and isotyping assays, and the proliferative responses of PBMC to measles and malarial antigens. This work will hopefully lead to enough data form the basis for a RO1 application.
描述

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISABELLA A QUAKYI其他文献

ISABELLA A QUAKYI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISABELLA A QUAKYI', 18)}}的其他基金

ACQUISITION OF IMMUNITY TO MALARIA IN CHILDREN AND ADULTS
儿童和成人获得疟疾免疫力
  • 批准号:
    6217108
  • 财政年份:
    1998
  • 资助金额:
    $ 2.52万
  • 项目类别:
CORE--VISITING SCIENTIST EXCHANGE PROGRAM
核心——访问科学家交流项目
  • 批准号:
    6217110
  • 财政年份:
    1998
  • 资助金额:
    $ 2.52万
  • 项目类别:
CORE--VISITING SCIENTIST EXCHANGE PROGRAM
核心——访问科学家交流项目
  • 批准号:
    6099800
  • 财政年份:
    1998
  • 资助金额:
    $ 2.52万
  • 项目类别:
ACQUISITION OF IMMUNITY TO MALARIA IN CHILDREN AND ADULTS
儿童和成人获得疟疾免疫力
  • 批准号:
    6099798
  • 财政年份:
    1998
  • 资助金额:
    $ 2.52万
  • 项目类别:
IMMUNE DISREGULATION IN MALARIA AND CONCOMMITANT MEASLES
疟疾和麻疹的免疫失调
  • 批准号:
    6031053
  • 财政年份:
    1998
  • 资助金额:
    $ 2.52万
  • 项目类别:
ACQUISITION OF IMMUNITY TO MALARIA IN CHILDREN AND ADULTS
儿童和成人获得疟疾免疫力
  • 批准号:
    6235234
  • 财政年份:
    1997
  • 资助金额:
    $ 2.52万
  • 项目类别:
CORE--VISITING SCIENTIST EXCHANGE PROGRAM
核心——访问科学家交流项目
  • 批准号:
    6235236
  • 财政年份:
    1997
  • 资助金额:
    $ 2.52万
  • 项目类别:
ACQUISITION OF IMMUNITY TO MALARIA IN CHILDREN AND ADULTS
儿童和成人获得疟疾免疫力
  • 批准号:
    3747608
  • 财政年份:
  • 资助金额:
    $ 2.52万
  • 项目类别:
ACQUISITION OF IMMUNITY TO MALARIA IN CHILDREN AND ADULTS
儿童和成人获得疟疾免疫力
  • 批准号:
    3727697
  • 财政年份:
  • 资助金额:
    $ 2.52万
  • 项目类别:
CORE--VISITING SCIENTIST EXCHANGE PROGRAM
核心——访问科学家交流项目
  • 批准号:
    3727699
  • 财政年份:
  • 资助金额:
    $ 2.52万
  • 项目类别:

相似海外基金

Development of a New Class of Broad-Stage Antimalarial Agents
新型多阶段抗疟药物的开发
  • 批准号:
    nhmrc : 2000087
  • 财政年份:
    2021
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Development Grants
Discovery of Small Molecules as Antimalarial Agents
作为抗疟剂的小分子的发现
  • 批准号:
    10312722
  • 财政年份:
    2021
  • 资助金额:
    $ 2.52万
  • 项目类别:
Synthetic Antibody Mimics as Antimalarial Agents
作为抗疟剂的合成抗体模拟物
  • 批准号:
    10161881
  • 财政年份:
    2020
  • 资助金额:
    $ 2.52万
  • 项目类别:
New aminobenzimidazole antimalarial agents with a novel mechanism of action
具有新作用机制的新型氨基苯并咪唑抗疟药
  • 批准号:
    nhmrc : GNT1163235
  • 财政年份:
    2019
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Project Grants
Investigating the pharmacology of 8-Aminoquinoline antimalarial agents.
研究 8-氨基喹啉抗疟药的药理学。
  • 批准号:
    2269400
  • 财政年份:
    2019
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Studentship
Kinase Targeted Antimalarial Agents
激酶靶向抗疟药
  • 批准号:
    9918203
  • 财政年份:
    2019
  • 资助金额:
    $ 2.52万
  • 项目类别:
Targeting the Plasmodium falciparum Metalloaminopeptidases for Development of New Antimalarial Agents
针对恶性疟原虫金属氨基肽酶开发新型抗疟药物
  • 批准号:
    nhmrc : 1063786
  • 财政年份:
    2014
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Project Grants
Search for antimalarial agents from microbial sources
从微生物来源寻找抗疟药物
  • 批准号:
    25860082
  • 财政年份:
    2013
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Defining the targets of broad intervention antimalarial agents
确定广泛干预抗疟药物的目标
  • 批准号:
    8892056
  • 财政年份:
    2013
  • 资助金额:
    $ 2.52万
  • 项目类别:
Defining the targets of broad intervention antimalarial agents
确定广泛干预抗疟药物的目标
  • 批准号:
    9109547
  • 财政年份:
    2013
  • 资助金额:
    $ 2.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了